Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
3,528 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00338247 | EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer | approved for marketing | — | — | NovartisINDUSTRY | 45 | Apr 6, 2016 | clinicaltrials |
| NCT00069108 | A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 627 | Hoffmann-La RocheINDUSTRY | 20 | Apr 1, 2016 | clinicaltrials |
| NCT00201422 |
| Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma |
| completed |
| N/A |
| 70 |
| National Health Research Institutes, TaiwanOTHER |
| 1 |
| Mar 28, 2016 |
| clinicaltrials |
| NCT00201357 | An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 2 | 30 | National Health Research Institutes, TaiwanOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT00201370 | A Multi-center Survey of HPV in Cervical Intraepithelial Neoplasia (CIN) With Longitudinal Follow-up of LSIL Cases | completed | — | 1,000 | National Health Research Institutes, TaiwanOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT00327132 | Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome | completed | N/A | 47 | National Health Research Institutes, TaiwanOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT02388581 | First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL | unknown | Phase 2 | 30 | National Health Research Institutes, TaiwanOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT02640924 | Proton Radiotherapy Versus Radiofrequency Ablation for Patients With Medium or Large Hepatocellular Carcinoma | unknown | Phase 3 | 166 | Chang Gung Memorial HospitalOTHER | 1 | Mar 21, 2016 | clinicaltrials |
| NCT02707835 | Edema Control in Patients With Breast Cancer-comparison of Manual Lymph Drainage and Epidermis Fascia Taping | unknown | N/A | 90 | National Taiwan University HospitalOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT01297491 | Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer(BASALT-1) | completed | Phase 2 | 63 | Novartis PharmaceuticalsINDUSTRY | 18 | Mar 11, 2016 | clinicaltrials |
| NCT00987935 | A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients | completed | Phase 2 | 134 | Boehringer IngelheimINDUSTRY | 2 | Mar 10, 2016 | clinicaltrials |
| NCT01254188 | Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients(ENESTxtnd) | completed | Phase 3 | 421 | Novartis PharmaceuticalsINDUSTRY | 19 | Mar 3, 2016 | clinicaltrials |
| NCT02608073 | A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer | completed | Phase 2 | 45 | Hoffmann-La RocheINDUSTRY | 5 | Mar 2, 2016 | clinicaltrials |
| NCT01665183 | Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma | completed | Phase 1 | 8 | Polaris GroupINDUSTRY | 2 | Feb 25, 2016 | clinicaltrials |
| NCT00455533 | Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer | completed | Phase 2 | 384 | Bristol-Myers SquibbINDUSTRY | 15 | Feb 24, 2016 | clinicaltrials |
| NCT01493921 | Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment | completed | Phase 3 | 113 | G&E Herbal Biotechnology Co., LTDINDUSTRY | 1 | Feb 19, 2016 | clinicaltrials |
| NCT00554229 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases(ENTHUSE M1) | completed | Phase 3 | 896 | AstraZenecaINDUSTRY | 31 | Feb 8, 2016 | clinicaltrials |
| NCT01584830 | Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy(CONCUR) | completed | Phase 3 | 204 | BayerINDUSTRY | 5 | Feb 8, 2016 | clinicaltrials |
| NCT01177631 | Proteomic Analysis of Human Hepatocellular Carcinoma | completed | N/A | 5 | Far Eastern Memorial HospitalOTHER | 1 | Feb 5, 2016 | clinicaltrials |
| NCT01956409 | Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis | unknown | Phase 4 | 80 | National Taiwan University HospitalOTHER | 1 | Feb 4, 2016 | clinicaltrials |
| NCT00526669 | Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib | completed | Phase 2 | 68 | GlaxoSmithKlineINDUSTRY | 6 | Jan 29, 2016 | clinicaltrials |
| NCT00333775 | A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer | completed | Phase 3 | 736 | Hoffmann-La RocheINDUSTRY | 24 | Jan 27, 2016 | clinicaltrials |
| NCT01256944 | To Study Polycystic Ovary Syndrome in Taiwanese Women | completed | — | 290 | Taipei Medical University WanFang HospitalOTHER | 1 | Jan 13, 2016 | clinicaltrials |
| NCT01874678 | A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer | completed | N/A | 45 | TTY BiopharmINDUSTRY | 1 | Jan 12, 2016 | clinicaltrials |
| NCT02563951 | Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers | completed | Phase 1 | 50 | Maxinase Life Sciences Ltd.INDUSTRY | 1 | Jan 8, 2016 | clinicaltrials |
| NCT01140347 | A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib(REACH) | completed | Phase 3 | 565 | Eli Lilly and CompanyINDUSTRY | 27 | Dec 28, 2015 | clinicaltrials |
| NCT02042313 | Postoperative Pain Management After Minimally Invasive Esophagectomy(MIEPVBEA) | unknown | Phase 4 | 58 | Sun Yat-sen UniversityOTHER | 1 | Dec 16, 2015 | clinicaltrials |
| NCT00883779 | A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | completed | Phase 3 | 451 | Hoffmann-La RocheINDUSTRY | 7 | Dec 14, 2015 | clinicaltrials |
| NCT01884129 | Prognostic Value of CTC in HNSCC Patients(CTCHNSCC01) | terminated | — | 53 | Chang Gung Memorial HospitalOTHER | 1 | Dec 10, 2015 | clinicaltrials |
| NCT00834236 | Proteiomic Fingerprints of Gastric Juice | completed | N/A | 76 | Kaohsiung Veterans General Hospital.OTHER | 1 | Dec 7, 2015 | clinicaltrials |
| NCT01232296 | A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment | completed | Phase 2 | 162 | Novartis PharmaceuticalsINDUSTRY | 7 | Dec 4, 2015 | clinicaltrials |
| NCT02133235 | The Need of Fiberoptic Bronchoscopy for Placing an Endobronchial Blocker | completed | N/A | 112 | National Taiwan University HospitalOTHER | 1 | Nov 23, 2015 | clinicaltrials |
| NCT00409188 | Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)(START) | completed | Phase 3 | 1,513 | EMD SeronoINDUSTRY | 33 | Nov 20, 2015 | clinicaltrials |
| NCT02605941 | DNA Methylation Biomarkers for Cervical Cancer Screening | unknown | — | 5,000 | iStat Biomedical CO., Ltd.INDUSTRY | 1 | Nov 17, 2015 | clinicaltrials |
| NCT01691300 | C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT(ACTMM) | completed | N/A | 30 | Chang Gung Memorial HospitalOTHER | 1 | Nov 13, 2015 | clinicaltrials |
| NCT02282839 | Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation | unknown | Phase 3 | 60 | Taichung Veterans General HospitalOTHER | 1 | Nov 4, 2015 | clinicaltrials |
| NCT00879333 | Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)(GRANITE-1) | completed | Phase 3 | 656 | Novartis PharmaceuticalsINDUSTRY | 22 | Nov 3, 2015 | clinicaltrials |
| NCT01842594 | A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma | terminated | Phase 2 | 13 | Shin Kong Wu Ho-Su Memorial HospitalOTHER | 1 | Nov 3, 2015 | clinicaltrials |
| NCT00768755 | Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 180 | PfizerINDUSTRY | 11 | Oct 28, 2015 | clinicaltrials |
| NCT02426216 | Molecular Effects of a Multi-carotenoids (MCS) New Agent on Prostate Cancer Chemoprevention | unknown | — | 300 | National Taiwan University HospitalOTHER | 1 | Oct 27, 2015 | clinicaltrials |
| NCT01234311 | A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer | completed | Phase 3 | 1,245 | Active Biotech ABINDUSTRY | 37 | Oct 21, 2015 | clinicaltrials |
| NCT01128998 | Sorafenib Plus S-1 in Advanced Solid Tumors | completed | Phase 1 | 30 | National Health Research Institutes, TaiwanOTHER | 1 | Oct 19, 2015 | clinicaltrials |
| NCT00743938 | A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC | completed | Phase 2 | 141 | Bristol-Myers SquibbINDUSTRY | 8 | Oct 12, 2015 | clinicaltrials |
| NCT01108705 | Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment(BRISK-APS) | terminated | Phase 3 | 87 | Bristol-Myers SquibbINDUSTRY | 4 | Oct 12, 2015 | clinicaltrials |
| NCT01549275 | Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration | completed | — | 105 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Oct 8, 2015 | clinicaltrials |
| NCT00656968 | Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection(960025) | completed | Phase 4 | 232 | Kaohsiung Veterans General Hospital.OTHER | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00373425 | A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors(RADIANT) | completed | Phase 3 | 1,252 | OSI PharmaceuticalsINDUSTRY | 19 | Sep 17, 2015 | clinicaltrials |
| NCT00528567 | BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer | completed | Phase 3 | 2,591 | Hoffmann-La RocheINDUSTRY | 40 | Sep 4, 2015 | clinicaltrials |
| NCT00630084 | Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma | completed | Phase 4 | 120 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Sep 4, 2015 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials